Unusual Presentation of Hydatid Cyst in Breast with Magnetic Resonance Imaging Findings

We report a case of 59-year-old woman with a painful left breast mass, compatible with types II-III hydatid cyst. Lesion was evaluated with mammography, ultrasound, computed tomography, and magnetic resonance imaging modalities. Magnetic resonance imaging had important diagnostic role with demonstrating characteristic features of the lesion and had capability of showing complications. Surgery also confirmed the diagnosis of a hydatid cyst.

http://ift.tt/2j6mP6T

Early-phase trial demonstrates shrinkage in pediatric neural tumors

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

http://ift.tt/2huW9uH

Cellular Immunotherapy Targets a Common Human Cancer Mutation

In a study of an immune therapy for colorectal cancer that involved a single patient, researchers identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene.

http://ift.tt/2gEcGcQ

No Safe Level of Smoking: Even low-intensity smokers are at increased risk of earlier death

People who consistently smoked an average of less than one cigarette per day over their lifetimes had a 64 percent higher risk of earlier death than people who never smoked.

http://ift.tt/2gM6K4A

NCI collaborates with Multiple Myeloma Research Foundation

The National Cancer Institute (NCI) announced a collaboration with the Multiple Myeloma Research Foundation (MMRF) to incorporate MMRF's wealth of genomic and clinical data on the disease into the NCI Genomic Data Commons (GDC), a publicly available database.

http://ift.tt/2duYdD4

NCI embraces scientific road map to achieve Cancer Moonshot goals

National Cancer Institute Acting Director Douglas Lowy, M.D., today accepted, with revisions that reflect NCAB's discussion, the recommendations of a Blue Ribbon Panel (BRP) on 10 approaches most likely to make a decade's worth of progress against cancer in five years, a key goal of the White House Cancer Moonshot.

http://ift.tt/2ihRNYp

Oxygen can impair cancer immunotherapy in mice

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers.

http://ift.tt/2ieVhI0